The effect of pharmacist-led medication therapy management in the multidisciplinary care of acute kidney injury survivors.

ABSTRACT:

Background

The Acute Disease Quality Initiative advocates multidisciplinary care for the survivors of acute kidney injury (AKI). The bundled care strategy recognizes the role of pharmacists. However, their specific contributions in this context remain underexplored.

Methods

This retrospective study examined the efficacy of pharmacist-led post-AKI pharmaceutical care in outpatient settings at a single center. Adults with recent AKI during hospitalization, maintaining an estimated glomerular filtration rate <45 mL/min/1.73 m2 postdischarge, were enrolled in a multidisciplinary team care program from March 2022 to January 2023, with a 6-month follow-up period. Pharmacist-delivered care adhered to international multidisciplinary consensus guidelines. Efficacy was evaluated by an

SUBMITTER: Wang T 

PROVIDER: S-EPMC11237329 | biostudies-literature | 2024 Jul

REPOSITORIES: biostudies-literature